Denali Therapeutics ( NASDAQ:DNLI ) First Quarter 2024 Results Key Financial Results Net loss: US$101.8m (loss narrowed...
Denali (DNLI) Q1 loss narrows year over year due to lower expenses despite nil revenues.
Insights into Denali Therapeutics' Financial Health and Strategic Developments